Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
784.50 DKK | -0.73% | +0.58% | +12.38% |
Dec. 12 | Novo Nordisk's Ozempic Gets EU Regulator Endorsement to Reduce Kidney Risks | DJ |
Dec. 12 | Europe allows Novo to include reduction of kidney disease in Ozempic label | RE |
MarketScreener Strategies
Novo Nordisk A/S: Volatility continues unabated | November 07, 2024 at 12:28 pm EST | |
Novo Nordisk doesn't disappoint | January 31, 2024 at 10:48 am EST | |
Novo Nordisk A/S : "With obesity, we're dealing with a billion patients worldwide". | August 25, 2023 at 09:40 am EDT | |
Novo Nordisk AS : Global leader in diabetes treatments | November 14, 2019 at 06:13 am EST |
Filters
Headlines
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- MarketScreener Strategies